Estropipate
CAS No. | 7280-37-7 | Cat. No. | BCP05424 |
Name | Estropipate | ||
Synonyms | Piperazine estrone sulfate; Harmogen; Ogen; Piperazine estronesulfate; | ||
Formula | C18H22O5S.C4H10N2 | M. Wt | 436.56 |
Description | Estropipate is a form of estrogen, an estrogen receptor agonist. It has several uses such as: Alleviate symptoms of menopause as hormone replacement therapy, treatment some types of infertility, treatment of some conditions leading to underdevelopment of female sexual characteristics, and treatment of prostate cancer and prevention of osteoporosis. Estropipate diffuses through the cell membrane and binds to and subsequently activates the nuclear estrogen receptor found in the reproductive tract, breast, pituitary, hypothalamus, liver, and bone. The activated complex binds to the estrogen response element on the DNA and activates the transcription of genes involved in the functioning of the female reproductive system and secondary sex characteristics. | ||
Pathways | Hormone Pathay | ||
Targets | Estrogen Receptor |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.